InvestorsHub Logo
Followers 1549
Posts 7854
Boards Moderated 4
Alias Born 02/26/2010

Re: patienttrac post# 24953

Sunday, 06/24/2018 7:00:07 PM

Sunday, June 24, 2018 7:00:07 PM

Post# of 107352
The whole deal makes no sense and you know it.

As a former shell TRON has no value to either InMed Group Inc or Continental Capital Corp.

If InMed Group Inc wanted to go public they'd just go public through a registration statement or they'd merge into an SEC registered Issuer not a former shell non-SEC registered pink sheet Issuer like TRON.

No financier would ever give capital to a former shell without an S-1 registration statement already filed to register the shares they would receive for the financing.

The only value TRON has is as an insider enrichment scheme for H Wayne Hayes Jr to sell his 70,000,000 shares that cost him only $20,000. I'm still not entirely sure based on H Wayne Hayes Jr's obvious status as a TRON insider that the 3(a)10 transaction was legal and not a violation of the Securities Act. I've sent my reseach to some SEC contacts to let them decide.

I suggest people read not only what has been going on with TRON and H. Wayne Hayes Jr but also look at what has been going on with CEOS, CRSM, and IICN

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141754038

You obviously know Rene Ortiz Morentin really well. How much did Rene Ortiz Morentin pay for the TRON shell? That information was never disclosed in the TRON OTC disclosures.

When Rene Ortiz Morentin bought the TRON shell did he have to pay H Wayne Hayes Jr for the shell (like what happened with IICN) or did he have to pay Adam Tracy? There is plenty of reason to believe that H Wayne Hayes Jr may have acquired the TRON shell from Adam Tracy then sold it to his buddy Rene Ortiz Morentin. Again that information wasn't in the TRON OTC disclosures.